Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, whether staying in hospital or attending as an outpatient
- People who are able to give informed consent to take part in the study
- People who are already scheduled to have a bronchoscopy (a procedure to look inside the airways) as part of their standard medical care for diagnosis or to check the stage of a condition
- People who are already having small tissue samples collected during their bronchoscopy procedure (using methods such as EBUS, TBNA, or transbronchial biopsy) as part of their routine care, not for research purposes
Who may not be able to join:
- People who have medical reasons that make bronchoscopy unsafe for them, including bleeding disorders, use of blood-thinning or anti-clotting medications, severe breathing problems, or being in an unstable medical condition
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeffrey Thiboutot, MD, Johns Hopkins University
Phone: 410-502-2533
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation of FFOCT to standard histology as assessed by the kappa value
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.